Pacific Research Institute
Coronavirus
PRI Covid Tradeoffs Brief Receives National Coverage
PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review
Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Newsom
Charles Kesler – Reflections on Current Contentions
This is a special recording of a recent PRI dinner in San Francisco featuring Professor Charles Kesler, the editor of the Claremont Review of Books, offering his perspective on U.S. politics and the global situation in Israel and China. Ro and Tim also weigh in on Gov. Newsom’s trip to ...
Commentary
Read latest about problems with PBMs
Decoupling PBM Fees Enhances Patient Outcomes
The three largest PBMs—Caremark (CVS Health/Aetna AET 0.0%), Express Scripts ESRX 0.0% (Cigna CI +0.7%), and OptumRx (UnitedHealth Group UNH +0.2%)—control 80% of the market and are integrated into large health insurance conglomerates. PBMs negotiate drug prices with pharmaceutical companies on behalf of insurers and manage their drug formularies. Read ...
California
Emily Hoeven – The Issues Facing San Francisco and California
sddasdasOur guest this week is Emily Hoeven, opinion columnist at The San Francisco Chronicle. Before coming to the Chronicle, she wrote CalMatters’ daily WhatMatters newsletter on California politics and policy and makes frequent appearances on TV, radio, podcasts, panels, and helped launch a weekly political segment on ABC 10. We ...
California
Rowena Itchon and Tim Anaya – California New Laws on the Books
It’s that time of the year when the Governor decides which bills to sign and which to veto. Rowena Itchon, chief operating officer at PRI and Tim Anaya, vice president of marketing and communications have a round-up discussion of the major bills — from health care to climate change to ...
Magazines
Impact Magazine Fall 2023
Talk of renewable energy and electric vehicle mandates are sweeping the nation as President Biden and blue states are looking to California’s energy policy as inspiration for big government energy policy. But by following California’s lead, the rest of the nation may soon suffer California’s fate of regular energy shortages ...
Covid-19
Wayne Winegarden – The Impact of Covid-19 Restrictions
Our guest this week is PRI senior fellow Dr. Wayne Winegarden. We discuss with Wayne his new study comparing the results of states that had very restrictive COVID-19 policies versus those that did not. He concludes that while COVID-19 restrictions did lead to some health benefits, they were unfortunately negated ...
Coronavirus
NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses
States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
California
Kerry Jackson – Climate Change and Big Oil
Our guest this week is Kerry Jackson, PRI’s senior fellow on California Reform. Kerry has been following Gov. Newsom’s and Attorney General Bonta’s lawsuit on oil companies and its implications. He also discusses SB 253, a corporate climate change disclosure bill; the federal and state push for electric busses including ...
Commentary
Read about problems of PBMs
Congress Waking Up to PBMs Drug Cost Manipulations
PBMs work for (or increasingly are part of) insurance companies. They decide which drugs patients can access and negotiate rebates to drugs’ list prices. The term “rebates” sounds like these discounts should benefit patients, but PBMs and insurers pocket these savings while basing patients’ costs on the higher undiscounted prices. ...
PRI Covid Tradeoffs Brief Receives National Coverage
PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review
Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Charles Kesler – Reflections on Current Contentions
This is a special recording of a recent PRI dinner in San Francisco featuring Professor Charles Kesler, the editor of the Claremont Review of Books, offering his perspective on U.S. politics and the global situation in Israel and China. Ro and Tim also weigh in on Gov. Newsom’s trip to ...
Read latest about problems with PBMs
Decoupling PBM Fees Enhances Patient Outcomes
The three largest PBMs—Caremark (CVS Health/Aetna AET 0.0%), Express Scripts ESRX 0.0% (Cigna CI +0.7%), and OptumRx (UnitedHealth Group UNH +0.2%)—control 80% of the market and are integrated into large health insurance conglomerates. PBMs negotiate drug prices with pharmaceutical companies on behalf of insurers and manage their drug formularies. Read ...
Emily Hoeven – The Issues Facing San Francisco and California
sddasdasOur guest this week is Emily Hoeven, opinion columnist at The San Francisco Chronicle. Before coming to the Chronicle, she wrote CalMatters’ daily WhatMatters newsletter on California politics and policy and makes frequent appearances on TV, radio, podcasts, panels, and helped launch a weekly political segment on ABC 10. We ...
Rowena Itchon and Tim Anaya – California New Laws on the Books
It’s that time of the year when the Governor decides which bills to sign and which to veto. Rowena Itchon, chief operating officer at PRI and Tim Anaya, vice president of marketing and communications have a round-up discussion of the major bills — from health care to climate change to ...
Impact Magazine Fall 2023
Talk of renewable energy and electric vehicle mandates are sweeping the nation as President Biden and blue states are looking to California’s energy policy as inspiration for big government energy policy. But by following California’s lead, the rest of the nation may soon suffer California’s fate of regular energy shortages ...
Wayne Winegarden – The Impact of Covid-19 Restrictions
Our guest this week is PRI senior fellow Dr. Wayne Winegarden. We discuss with Wayne his new study comparing the results of states that had very restrictive COVID-19 policies versus those that did not. He concludes that while COVID-19 restrictions did lead to some health benefits, they were unfortunately negated ...
NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses
States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Kerry Jackson – Climate Change and Big Oil
Our guest this week is Kerry Jackson, PRI’s senior fellow on California Reform. Kerry has been following Gov. Newsom’s and Attorney General Bonta’s lawsuit on oil companies and its implications. He also discusses SB 253, a corporate climate change disclosure bill; the federal and state push for electric busses including ...
Read about problems of PBMs
Congress Waking Up to PBMs Drug Cost Manipulations
PBMs work for (or increasingly are part of) insurance companies. They decide which drugs patients can access and negotiate rebates to drugs’ list prices. The term “rebates” sounds like these discounts should benefit patients, but PBMs and insurers pocket these savings while basing patients’ costs on the higher undiscounted prices. ...
